{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T01:08:03Z","timestamp":1775092083600,"version":"3.50.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"7th Framework Program Risky CAD","award":["305739"],"award-info":[{"award-number":["305739"]}]},{"name":"H2020 Program TO_AITION","award":["848146"],"award-info":[{"award-number":["848146"]}]},{"DOI":"10.13039\/501100012264","name":"NIH","doi-asserted-by":"publisher","award":["R01 HL133399"],"award-info":[{"award-number":["R01 HL133399"]}],"id":[{"id":"10.13039\/501100012264","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Serum uromodulin (SUmod) and carbamylated albumin (C-Alb) are emerging biomarkers for chronic kidney disease (CKD) progression and mortality. SUmod reflects tubular health, while C-Alb is associated with excretory kidney function, CKD progression, and cardiovascular (CV) mortality. We hypothesized that the combined use of these markers would improve mortality risk assessments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed the associations of C-Alb and SUmod levels with the estimated glomerular filtration rate (eGFR) along with their combined predictive value for assessing mortality in 3316 participants of the Ludwigshafen Risk and Cardiovascular Health study showing mid to high CV risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SUmod correlated moderately with eGFR (\u03c1 = 0.39, P &amp;lt; 0.001) and weakly and inversely with C-Alb (\u03c1 = \u22120.19, P &amp;lt; 0.001); C-Alb negatively correlated with eGFR (\u03c1 = \u22120.38, P &amp;lt; 0.001). Patients in the C-Alb high\/SUmod low group had the highest mortality risk [hazard ratio (HR)= 3.30; 95% CI, 2.73\u20133.99], which remained significant after adjustment for confounders, including eGFR (HR = 1.89; 95% CI, 1.24\u20131.89). In risk-prediction models for all-cause mortality, adding SUmod increased the area under the curve (AUC) from 0.728 to 0.746 (P &amp;lt; 0.001), C-Alb to 0.738 (P = 0.026), and both combined to 0.751 (P &amp;lt; 0.001). For CV mortality, AUC rose from 0.698 to 0.721 with SUmod (P &amp;lt; 0.001), to 0.711 with C-Alb (P = 0.018), and to 0.727 (P = 0.004) in the combined model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SUmod and C-Alb levels yield complementary insights into kidney function, biology, and mortality risk beyond eGFR. Low SUmod\/high C-Alb revealed the highest mortality risk, even after multivariate adjustment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>German Clinical Trials Register Number<\/jats:title>\n                    <jats:p>DRKS00032641.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/clinchem\/hvaf166","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T13:07:54Z","timestamp":1763039274000},"page":"408-418","source":"Crossref","is-referenced-by-count":1,"title":["Association of Serum Uromodulin and Carbamylated Albumin with All-Cause and Cardiovascular Mortality in Patients with No or Mild Chronic Kidney Disease"],"prefix":"10.1093","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0388-3098","authenticated-orcid":false,"given":"Clara","family":"Daschner","sequence":"first","affiliation":[{"name":"Nephrologisches MVZ Mannheim, ze:ro Praxen , Mannheim ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus E","family":"Kleber","sequence":"additional","affiliation":[{"name":"Synlab Humangenetik, SYNLAB Holding Deutschland GmbH , Mannheim ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders H","family":"Berg","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center , Los Angeles, CA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6742-5052","authenticated-orcid":false,"given":"Faeq","family":"Husain-Syed","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Division of Nephrology, University Hospital Giessen and Marburg, Justus-Liebig-University Giessen , Giessen ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen E","family":"Scherberich","sequence":"additional","affiliation":[{"name":"Klinikum Munich-Harlaching, Ludwig-Maximilians University , Munich ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard K","family":"Kr\u00e4mer","sequence":"additional","affiliation":[{"name":"Medical Faculty Mannheim of the University of Heidelberg , Mannheim ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winfried","family":"M\u00e4rz","sequence":"additional","affiliation":[{"name":"Synlab Academy, SYNLAB Holding Deutschland GmbH , Mannheim and Augsburg ,","place":["Germany"]},{"name":"Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz , Graz ,","place":["Austria"]},{"name":"Department of Cardiology, Medical Faculty Heidelberg of the University of Heidelberg , Heidelberg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9222-8958","authenticated-orcid":false,"given":"Babak","family":"Yazdani","sequence":"additional","affiliation":[{"name":"Fifth Department of Medicine (Nephrology, Hypertensiology, Rheumatology, Endocrinology, Diabetology, Pneumology), University Medical Center Mannheim UMM, Faculty of Medicine of the University of Heidelberg , Mannheim ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"2026030508530686600_hvaf166-B1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","journal-title":"Lancet"},{"key":"2026030508530686600_hvaf166-B2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3181\/00379727-74-17825","article-title":"Characterization and separation of an inhibitor of viral hemagglutination present in urine","volume":"74","author":"Tamm","year":"1950","journal-title":"Proc Soc Exp Biol Med"},{"key":"2026030508530686600_hvaf166-B3","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.2215\/CJN.04480413","article-title":"Thick ascending limb of the loop of henle","volume":"9","author":"Mount","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026030508530686600_hvaf166-B4","doi-asserted-by":"crossref","first-page":"F1066","DOI":"10.1152\/ajprenal.00543.2012","article-title":"Tamm-Horsfall protein translocates to the basolateral domain of thick ascending limbs, interstitium, and circulation during recovery from acute kidney injury","volume":"304","author":"El-Achkar","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026030508530686600_hvaf166-B5","doi-asserted-by":"crossref","first-page":"F403","DOI":"10.1152\/ajprenal.00322.2021","article-title":"The kidney releases a nonpolymerizing form of uromodulin in the urine and circulation that retains the external hydrophobic patch domain","volume":"322","author":"Micanovic","year":"2022","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026030508530686600_hvaf166-B6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/nep.13688","article-title":"Association of serum and urinary uromodulin and their correlates in older adults-the cardiovascular health study","volume":"25","author":"Steubl","year":"2020","journal-title":"Nephrology (Carlton)"},{"key":"2026030508530686600_hvaf166-B7","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1681\/ASN.2016111162","article-title":"Serum uromodulin and mortality risk in patients undergoing coronary angiography","volume":"28","author":"Delgado","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2026030508530686600_hvaf166-B8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/j.ajkd.2023.05.017","article-title":"Associations of baseline and longitudinal serum uromodulin with kidney failure and mortality: results from the African American Study of Kidney disease and hypertension (AASK) trial","volume":"83","author":"Chen","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"2026030508530686600_hvaf166-B9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrneph.2017.101","article-title":"Uromodulin: from physiology to rare and complex kidney disorders","volume":"13","author":"Devuyst","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2026030508530686600_hvaf166-B10","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/ndt\/gfw422","article-title":"Serum uromodulin-a marker of kidney function and renal parenchymal integrity","volume":"33","author":"Scherberich","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2026030508530686600_hvaf166-B11","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/s41581-024-00881-7","article-title":"Advances in uromodulin biology and potential clinical applications","volume":"20","author":"Nanamatsu","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"2026030508530686600_hvaf166-B12","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/cvr\/cvaa081","article-title":"Circulating uromodulin inhibits vascular calcification by interfering with pro-inflammatory cytokine signalling","volume":"117","author":"Alesutan","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2026030508530686600_hvaf166-B13","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1042\/bj0420628","article-title":"The isomeric transformation of urea into ammonium cyanate in aqueous solutions","volume":"42","author":"Dirnhuber","year":"1948","journal-title":"Biochem J"},{"key":"2026030508530686600_hvaf166-B14","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrneph.2017.103","article-title":"Mechanisms and consequences of carbamoylation","volume":"13","author":"Delanghe","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2026030508530686600_hvaf166-B15","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1046\/j.1523-1755.2001.59780102.x","article-title":"Carbamoylation of amino acids and proteins in uremia","volume":"78","author":"Kraus","year":"2001","journal-title":"Kidney Int Suppl"},{"key":"2026030508530686600_hvaf166-B16","doi-asserted-by":"crossref","first-page":"175ra29","DOI":"10.1126\/scitranslmed.3005218","article-title":"Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure","volume":"5","author":"Berg","year":"2013","journal-title":"Sci Transl Med"},{"key":"2026030508530686600_hvaf166-B17","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/ndt\/gfv048","article-title":"Emerging role of post-translational modifications in chronic kidney disease and cardiovascular disease","volume":"30","author":"Gajjala","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2026030508530686600_hvaf166-B18","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nm1637","article-title":"Protein carbamylation links inflammation, smoking, uremia and atherogenesis","volume":"13","author":"Wang","year":"2007","journal-title":"Nat Med"},{"key":"2026030508530686600_hvaf166-B19","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1681\/ASN.0000000000000078","article-title":"Protein carbamylation and the risk of ESKD in patients with CKD","volume":"34","author":"Kalim","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"2026030508530686600_hvaf166-B20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/clinchem\/hvaf021","article-title":"Carbamylated albumin, heart failure, and mortality in patients undergoing coronary angiography","volume":"71","author":"Yazdani","year":"2025","journal-title":"Clin Chem"},{"key":"2026030508530686600_hvaf166-B21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000543143","article-title":"Association between arterial stiffness, carbamylation, and mortality in patients undergoing coronary angiography with no or mild chronic kidney disease","volume":"15","author":"Daschner","year":"2024","journal-title":"Cardiorenal Med"},{"key":"2026030508530686600_hvaf166-B22","doi-asserted-by":"crossref","first-page":"e1257","DOI":"10.34067\/KID.0000000000000226","article-title":"Urinary biomarkers of kidney tubule health and mortality in persons with CKD and diabetes mellitus","volume":"4","author":"Vasquez-Rios","year":"2023","journal-title":"Kidney360"},{"key":"2026030508530686600_hvaf166-B23","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.2215\/CJN.03600318","article-title":"Uromodulin and nephron mass","volume":"13","author":"Pivin","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026030508530686600_hvaf166-B24","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1517\/14622416.2.1.S1","article-title":"Rationale and design of the LURIC study\u2013a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease","volume":"2","author":"Winkelmann","year":"2001","journal-title":"Pharmacogenomics"},{"key":"2026030508530686600_hvaf166-B25","doi-asserted-by":"crossref","first-page":"e3011","DOI":"10.1097\/MD.0000000000003011","article-title":"Plasma uromodulin correlates with kidney function and identifies early stages in chronic kidney disease patients","volume":"95","author":"Steubl","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2026030508530686600_hvaf166-B26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1258\/acb.2008.008029","article-title":"Simultaneous determination of guanidinoacetate, creatine and creatinine in urine and plasma by un-derivatized liquid chromatography-tandem mass spectrometry","volume":"45","author":"Carling","year":"2008","journal-title":"Ann Clin Biochem"},{"key":"2026030508530686600_hvaf166-B27","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"2026030508530686600_hvaf166-B28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"2026030508530686600_hvaf166-B29","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"2026030508530686600_hvaf166-B30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12967-025-06125-x","article-title":"Serum uromodulin as early marker for ischemic acute kidney injury and nephron loss: association with kidney tissue distribution pattern","volume":"23","author":"Vonbrunn","year":"2025","journal-title":"J Transl Med"},{"key":"2026030508530686600_hvaf166-B31","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/ckj\/sfaa165","article-title":"Serum uromodulin is inversely associated with biomarkers of subclinical inflammation in the population-based KORA F4 study","volume":"14","author":"Then","year":"2021","journal-title":"Clin Kidney J"},{"key":"2026030508530686600_hvaf166-B32","doi-asserted-by":"crossref","first-page":"F999","DOI":"10.1152\/ajprenal.00621.2010","article-title":"Tamm-Horsfall protein-deficient thick ascending limbs promote injury to neighboring S3 segments in an MIP-2-dependent mechanism","volume":"300","author":"El-Achkar","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026030508530686600_hvaf166-B33","doi-asserted-by":"crossref","first-page":"e0116206","DOI":"10.1371\/journal.pone.0116206","article-title":"Systemic inflammation predicts all-cause mortality: a Glasgow inflammation outcome study","volume":"10","author":"Proctor","year":"2015","journal-title":"PLoS One"},{"key":"2026030508530686600_hvaf166-B34","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1093\/eurheartj\/ehu059","article-title":"C-reactive protein and risk of cardiovascular and all-cause mortality in 268 803 East Asians","volume":"35","author":"Sung","year":"2014","journal-title":"Eur Heart J"},{"key":"2026030508530686600_hvaf166-B35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/ijms21010263","article-title":"Inflammation and oxidative stress in chronic kidney disease-potential therapeutic role of minerals, vitamins and plant-derived metabolites","volume":"21","author":"Rapa","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026030508530686600_hvaf166-B36","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/CIRCRESAHA.122.321749","article-title":"Innate immunity system in patients with cardiovascular and kidney disease","volume":"132","author":"Zoccali","year":"2023","journal-title":"Circ Res"},{"key":"2026030508530686600_hvaf166-B37","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"key":"2026030508530686600_hvaf166-B38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1172\/jci.insight.167731","article-title":"Longitudinal biomarkers and kidney disease progression after acute kidney injury","volume":"8","author":"Wen","year":"2023","journal-title":"JCI Insight"},{"key":"2026030508530686600_hvaf166-B39","doi-asserted-by":"crossref","first-page":"2444396","DOI":"10.1080\/0886022X.2024.2444396","article-title":"Construction of a C-reactive protein-albumin-lymphocyte index-based prediction model for all-cause mortality in patients on maintenance hemodialysis","volume":"47","author":"Huang","year":"2025","journal-title":"Ren Fail"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/72\/3\/408\/65913370\/hvaf166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/72\/3\/408\/65913370\/hvaf166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T13:53:16Z","timestamp":1772718796000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/72\/3\/408\/8381271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,12,16]]},"published-print":{"date-parts":[[2026,3,5]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvaf166","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,12,16]]}}}